Palisade Bio (PALI) Enterprise Value Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -191.56% |
| Dec 31, 2025 | -184.29% |
| Sep 30, 2025 | -47.41% |
| Jun 30, 2025 | -28.96% |
| Mar 31, 2025 | 6.34% |
| Dec 31, 2024 | -13.80% |
| Sep 30, 2024 | -1.95% |
| Jun 30, 2024 | -37.84% |
| Mar 31, 2024 | -23.00% |
| Dec 31, 2023 | -16.52% |
| Sep 30, 2023 | -21.69% |
| Jun 30, 2023 | -18.26% |
| Mar 31, 2023 | -6.46% |
| Dec 31, 2022 | -1.18% |
| Sep 30, 2022 | 0.11% |
| Jun 30, 2022 | 15.33% |
| Mar 31, 2022 | 16.82% |
| Dec 31, 2021 | 12.27% |
| Sep 30, 2021 | -19.97% |
| Jun 30, 2021 | -2.60% |
| Mar 31, 2021 | 39.55% |
| Dec 31, 2020 | 43.36% |
| Sep 30, 2020 | 47.11% |
| Jun 30, 2020 | 42.27% |
| Mar 31, 2020 | 18.92% |
| Dec 31, 2019 | 28.58% |
| Sep 30, 2019 | 22.99% |
| Jun 30, 2019 | 40.36% |
| Mar 31, 2019 | 34.55% |
| Dec 31, 2018 | 19.24% |
| Sep 30, 2018 | 18.95% |
| Jun 30, 2018 | 8.68% |
| Mar 31, 2018 | 5.14% |
| Dec 31, 2017 | -9.42% |
| Sep 30, 2017 | -7.33% |
| Jun 30, 2017 | -35.13% |
| Mar 31, 2017 | -26.53% |
| Dec 31, 2016 | -53.73% |
| Sep 30, 2016 | -6.23% |
| Jun 30, 2016 | -12.62% |
| Mar 31, 2016 | 2.27% |
| Dec 31, 2015 | -5.73% |
| Sep 30, 2015 | -9.39% |
| Jun 30, 2015 | -11.04% |